22nd Century Group

09/12/2023

Today, 22nd Century Group, Inc. announced its FDA authorized VLN® reduced ni****ne content ci******es designed specifically to promote to***co harm reduction are now available at more than 1,200 drug store locations across Texas, Florida, Illinois, North Carolina, and Georgia beginning in September.

Read the full press release here: xxii.bio/1200StoresPR

08/29/2023

Explore the intricacies of the Endocannabinoid System (ECS) and its profound impact on human health and wellness. Discover the functions, mechanics, and significance of the ECS in our latest video.

08/14/2023

Today, 22nd Century Group reported results for the Second quarter ended June 30, 2023, and provided an update on recent business highlights.

“Our focus in 2023 remains 22nd Century’s transformation from a primary emphasis on research and development to a fully commercial enterprise providing innovative harm reduction and consumer health and wellness products to key end markets. We have now significantly advanced our commercialization plan for VLN® sales across targeted states, 14 of which are now in place and two more states scheduled in September with a new drug store customer, a diversified h**p/cannabis ingredients and distribution business and a robust license and distribution business in both to***co and h**p/cannabis,” and said John Miller, interim Chief Executive Officer of 22nd Century Group.

Read the full press release here: http://xxii.bio/2023Q2

08/09/2023

Through our subsidiary GVB Biopharma, we're setting new standards in the h**p and cannabis industry with relentless commitment and unrivaled quality.

08/07/2023

On Monday, August 14, 2023, at 10:00 AM ET, 22nd Century Group will host a live webcast to discuss its 2023 second-quarter results, which are to be reported in a press release at 6:00 AM ET the same day.

Read the full press release here:

BUFFALO, N.Y., Aug. 07, 2023 (GLOBE NEWSWIRE) - 22nd Century Group, Inc. (Nasdaq: XXII ), a leading biotechnology company dedicated to improving health with reduced ni****ne to***co, h**p/cannabis and hops advanced plant technologies, will host a live webcast on Monday, August 14, 2023, at 10:00 AM....

08/04/2023

A smoke-free future is within reach. Join 22nd Century Group's mission and read our inaugural blog post to learn about our goal to sell the last cigarette before the 22nd century.

One of 22nd Century Group’s goals is to sell the last combustible to***co cigarette before the start of the 22nd Century. To achieve this, we are now selling the world’s first and only FDA-authorized reduced ni****ne content cigarette, designed specifically to break the chains of ni****ne addict...

07/17/2023

This week, 22nd Century Group launched VLN® King ci******es, the first-ever reduced ni****ne combustible cigarette, in the California market.

Starting July 17th, VLN® products, which contain a staggering 95% less ni****ne than conventional ci******es, will be conveniently available in CA at more than 275 sites of the #1 convenience store in the US, in addition to numerous other convenience stores across CA.

“We see our VLN® product offering Californians who smoke a tremendous new option because VLN® ci******es are specifically designed to help smokers smoke less, increase their number of smoke-free days and reduce their ni****ne exposure and dependence,” said John Miller, 22nd Century Group President, To***co Division. “Our goal with VLN® is to meet California consumers where they are with a combustible product that helps people smoke less.”

VLN® King ci******es have made history by receiving U.S. Food & Drug Administration (FDA) approval as a modified risk to***co product (MRTP).

Read the full press release here: xxii.bio/VLNCA